Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.63 - $2.96 $313,992 - $1.48 Million
498,400 New
498,400 $897,000
Q4 2021

Feb 11, 2022

SELL
$2.7 - $4.76 $472,500 - $833,000
-175,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$4.06 - $5.8 $2.13 Million - $3.05 Million
-525,000 Reduced 75.0%
175,000 $780,000
Q2 2021

Aug 16, 2021

BUY
$5.02 - $7.05 $3.26 Million - $4.58 Million
650,000 Added 1300.0%
700,000 $4.06 Million
Q3 2020

Nov 16, 2020

SELL
$4.82 - $7.72 $1.93 Million - $3.09 Million
-400,000 Reduced 88.89%
50,000 $291,000
Q2 2020

Aug 14, 2020

SELL
$5.69 - $9.69 $3.34 Million - $5.68 Million
-586,500 Reduced 56.58%
450,000 $3.04 Million
Q1 2020

May 15, 2020

BUY
$3.77 - $11.0 $543,634 - $1.59 Million
144,200 Added 16.16%
1,036,500 $6.59 Million
Q4 2019

Feb 13, 2020

BUY
$3.0 - $16.43 $2.01 Million - $11 Million
669,800 Added 301.03%
892,300 $9.3 Million
Q3 2019

Nov 14, 2019

BUY
$3.93 - $15.35 $638,625 - $2.49 Million
162,500 Added 270.83%
222,500 $874,000
Q2 2019

Aug 13, 2019

SELL
$12.81 - $25.67 $2.69 Million - $5.39 Million
-210,000 Reduced 77.78%
60,000 $892,000
Q1 2019

May 14, 2019

BUY
$17.66 - $30.28 $4.77 Million - $8.18 Million
270,000 New
270,000 $6.7 Million
Q4 2018

Jan 30, 2019

SELL
$11.63 - $32.67 $566,381 - $1.59 Million
-48,700 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$29.37 - $49.48 $1.43 Million - $2.41 Million
48,700 New
48,700 $1.43 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.